# Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

> **NCT00688246** · — · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 238 (actual)

## Conditions studied

- Breast Cancer
- Osteoporosis

## Interventions

- **OTHER:** biologic sample preservation procedure
- **PROCEDURE:** dual x-ray absorptometry

## Key facts

- **NCT ID:** NCT00688246
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-10
- **Primary completion:** 2011-10-31
- **Final completion:** 2013-01-10
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688246, "Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00688246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*